Live Status Check

NCT05065554 Recruiting Status

Real-time enrollment status for this igm neuropathy clinical trial

Current Status

Active, Not Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 12:22 PM UTC

NCT05065554 Status Summary

NCT NumberNCT05065554
Recruiting StatusActive, Not Recruiting
ConditionIgM Neuropathy
PhaseClinical Trial
Target Enrollment33 participants
Active Locations2 sites in the US
SponsorShayna Sarosiek, MD
Last Updated on CT.govDecember 5, 2025 (Dec 5, 2025)

About NCT05065554 Enrollment Status

As of March 2, 2026: Clinical trial NCT05065554 is currently active_not_recruiting participants. This clinical trial study for igm neuropathy is not currently accepting new participants at 2 locations across the United States. The study is sponsored by Shayna Sarosiek, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05065554

Is NCT05065554 still recruiting?

No, NCT05065554 is currently active_not_recruiting. The study may resume recruiting in the future.

Where is NCT05065554 recruiting?

This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05065554?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05065554 status last updated?

The official ClinicalTrials.gov record for NCT05065554 was last updated Dec 5, 2025 (December 5, 2025). HelloStudys verifies this status automatically.

Browse More IgM Neuropathy Trials

Want to Learn More?

View full study details and sign up for status updates